Skip to main navigation
Skip to search
Skip to main content
Technical University of Munich Home
Help & FAQ
English
Deutsch
Home
Profiles
Research units
Projects
Research output
Equipment
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Pathophysiology of superficial femoral artery in-stent restenosis
K. Yahagi
, F. Otsuka
, K. Sakakura
, O. D. Sanchez
, R. Kutys
, E. Ladich
, F. D. Kolodgie
, R. Virmani
,
M. Joner
CVPath Institute, Inc.
Research output
:
Contribution to journal
›
Review article
›
peer-review
59
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pathophysiology of superficial femoral artery in-stent restenosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pathophysiology
100%
Superficial Femoral Artery
100%
In-stent Restenosis
100%
Restenosis
66%
Collagen
33%
United States
33%
Morphological Characteristics
33%
Necrotic Core
33%
Moderate to Severe
33%
Atherosclerotic Disease
33%
Coronary Atherosclerosis
33%
Aging Population
33%
Balloon Angioplasty
33%
Metabolic Syndrome
33%
Effective Therapy
33%
Proteoglycan
33%
Everyday Practices
33%
Being Adopted
33%
Peripheral Arterial Disease
33%
Drug-eluting Stent
33%
Cell Deposition
33%
Endovascular Therapy
33%
Smooth muscle Cell Proliferation
33%
Patency Rate
33%
Carotid Atherosclerotic Disease
33%
Diabetes Incidence
33%
Severe Calcification
33%
Fibrous Plaque
33%
Diabetes Syndrome
33%
Challenging Problems
33%
Emerging Problems
33%
Drug-coated Balloon
33%
Medicine and Dentistry
Pathophysiology
100%
In-Stent Restenosis
100%
Superficial Femoral Artery
100%
Restenosis
66%
Diseases
66%
Morphology
33%
Diabetes
33%
Cell Proliferation
33%
Stenting
33%
Smooth Muscle Cell
33%
Metabolic Syndrome
33%
Arteriosclerosis Obliterans
33%
Carotid Atherosclerosis
33%
Drug-Eluting Stent
33%
Endovascular Surgery
33%
Percutaneous Transluminal Angioplasty
33%
Proteoglycan
33%
Pharmacology, Toxicology and Pharmaceutical Science
In-Stent Restenosis
100%
Pathophysiology
100%
Restenosis
100%
Diseases
100%
Proteoglycan
50%
Metabolic Syndrome X
50%
Peripheral Occlusive Artery Disease
50%
Carotid Atherosclerosis
50%